Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-gamma and TNF-alpha and enhancement of IL-10

Citation
R. Di Marco et al., Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-gamma and TNF-alpha and enhancement of IL-10, J AUTOIMMUN, 13(2), 1999, pp. 187-195
Citations number
48
Categorie Soggetti
Immunology
Journal title
JOURNAL OF AUTOIMMUNITY
ISSN journal
08968411 → ACNP
Volume
13
Issue
2
Year of publication
1999
Pages
187 - 195
Database
ISI
SICI code
0896-8411(199909)13:2<187:AOEANB>2.0.ZU;2-2
Abstract
The immunomodulating antibiotic drug fusidic acid and its sodium salt sodiu m fusidate (fusidin) ameliorate several organ-specific immunoinflammatory d iseases. Because preliminary observations suggest that fusidin may also exe rt a beneficial effect in Guillain-Barre syndrome (GBS), here we have studi ed the effects of fusidin on actively induced experimental autoimmune neuri tis (EAN) in rats, a known animal model for GBS. Both prophylactic and ther apeutic treatment with fusidin (4 mg/rat day ip) markedly ameliorated the c linical course of the disease compared to vehicle-treated animals. The bene ficial effects were associated with profound modifications of the capacity of these rats to produce and release pro- and anti-inflammatory cytokines s uch as IFN-gamma, TNF-alpha and IL-10, which are important in regulating th e development of EAN. (C) 1999 Academic Press.